** Piper Sandler upgrades medical device maker Solventum SOLV.N to "overweight" from "neutral", raises PT to $87 from $78
** New PT implies 14.8% upside to stock's last close
** Brokerage says co has shown strong execution, with four quarters of clean beats and slight guidance raises, indicating that management is on right track
** Says co has showed consistent improvement in top-line growth and margins
** SOLV's tariff risk appears meaningfully lessened following recent U.S.-China trade tension de-escalation, Piper Sandler says
**Brokerage adds EPS estimates for SOLV have potential upside, driven by co's restructuring efforts, becoming fully independent from its former parent 3M MMM.N and efforts to remove unprofitable products
** Including session's moves, SOLV stock up 12.7% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。